AQR Capital Management
CASI

AQR Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

AQR Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,806
Closed -$122K – 2115
2019
Q2 		$122K Sell
3,806
-1,164
-23% -$37.2K ﹤0.01% 2026
2019
Q1 		$143K Sell
4,970
-2,843
-36% -$99.1K ﹤0.01% 2110
2018
Q4 		$314K Sell
7,813
-1,057
-12% -$40K ﹤0.01% 1950
2018
Q3 		$414K Buy
8,870
+1,235
+16% +$86.2K ﹤0.01% 2009
2018
Q2 		$628K Buy
+7,635
New +$515K ﹤0.01% 1906

Other funds holding CASI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

AQR Capital Management's CASI Position: Q3 2019 in Review

AQR Capital Management sold out of CASI Pharmaceuticals (CASI) in Q3 2019, closing a stake of 3,806 shares — an estimated $122K sold.

AQR Capital Management first reported a position in CASI in Q2 2018 and held it in 5 quarters. The position peaked at $628K in Q2 2018. 51 funds tracked by Wall St. Rank hold CASI as of Q3 2019.

  • AQR Capital Management reported no remaining CASI Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • AQR Capital Management sold 3,806 CASI Pharmaceuticals shares in Q3 2019, an estimated $122K.
  • AQR Capital Management first reported a position in CASI Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • AQR Capital Management's CASI Pharmaceuticals position peaked at $628K in Q2 2018.
  • 51 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2019.

Based on AQR Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.